Espitia Morillo C, Meyer J
Viruses. 2022; 14(12).
PMID: 36560753
PMC: 9786322.
DOI: 10.3390/v14122749.
Espitia C, Botina M, Solarte M, Hernandez I, Riascos R, Meyer J
J Comput Biol. 2022; 29(5):483-493.
PMID: 35544039
PMC: 9125573.
DOI: 10.1089/cmb.2021.0323.
Tomasik A, Pokorska-Spiewak M, Marczynska M
Pediatr Rep. 2021; 13(4):566-575.
PMID: 34698220
PMC: 8544719.
DOI: 10.3390/pediatric13040067.
Krueger E, Holloway I, Lightfoot M, Lin A, Hammack P, Meyer I
LGBT Health. 2020; 7(4):190-197.
PMID: 32298607
PMC: 7301327.
DOI: 10.1089/lgbt.2019.0280.
Barre-Sinoussi F, Abdool Karim S, Albert J, Bekker L, Beyrer C, Cahn P
J Int AIDS Soc. 2018; 21(7):e25161.
PMID: 30044059
PMC: 6058263.
DOI: 10.1002/jia2.25161.
Role of survey response rates on valid inference: an application to HIV prevalence estimates.
Marino M, Pagano M
Emerg Themes Epidemiol. 2018; 15:6.
PMID: 29527231
PMC: 5839032.
DOI: 10.1186/s12982-018-0074-x.
The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011-2013.
Nosyk B, Min J, Krebs E, Zang X, Compton M, Gustafson R
Clin Infect Dis. 2017; 66(5):765-777.
PMID: 29028964
PMC: 5850008.
DOI: 10.1093/cid/cix832.
Cost-Effectiveness of the 'One4All' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China.
Zang X, Tang H, Min J, Gu D, Montaner J, Wu Z
PLoS One. 2016; 11(11):e0167308.
PMID: 27893864
PMC: 5125690.
DOI: 10.1371/journal.pone.0167308.
Clinical efficacy of a combination of Percoll continuous density gradient and swim-up techniques for semen processing in HIV-1 serodiscordant couples.
Inoue O, Kuji N, Ito H, Yamada M, Hamatani T, Oyadomari A
Asian J Androl. 2016; 19(2):208-213.
PMID: 26908065
PMC: 5312220.
DOI: 10.4103/1008-682X.173442.
Current perspectives in HIV post-exposure prophylaxis.
Sultan B, Benn P, Waters L
HIV AIDS (Auckl). 2014; 6:147-58.
PMID: 25368534
PMC: 4216036.
DOI: 10.2147/HIV.S46585.
HIV transmission among men who have sex with men due to condom failure.
Remis R, Alary M, Liu J, Kaul R, Palmer R
PLoS One. 2014; 9(9):e107540.
PMID: 25211493
PMC: 4161430.
DOI: 10.1371/journal.pone.0107540.
Expanded HIV testing in low-prevalence, high-income countries: a cost-effectiveness analysis for the United Kingdom.
Long E, Mandalia R, Mandalia S, Alistar S, Beck E, Brandeau M
PLoS One. 2014; 9(4):e95735.
PMID: 24763373
PMC: 3998955.
DOI: 10.1371/journal.pone.0095735.
A systematic review of heterosexual anal intercourse and its role in the transmission of HIV and other sexually transmitted infections in Papua New Guinea.
Kelly-Hanku A, Vallely A, Man W, Wilson D, Law G, Gray R
BMC Public Health. 2013; 13:1108.
PMID: 24289271
PMC: 4219522.
DOI: 10.1186/1471-2458-13-1108.
Advances in the prevention of heterosexual transmission of HIV/AIDS among women in the United States.
Chen N, Meyer J, Springer S
Infect Dis Rep. 2013; 3(1).
PMID: 23745166
PMC: 3671603.
DOI: 10.4081/idr.2011.e6.
Condom distribution in jail to prevent HIV infection.
Leibowitz A, Harawa N, Sylla M, Hallstrom C, Kerndt P
AIDS Behav. 2012; 17(8):2695-702.
PMID: 22555381
PMC: 3786088.
DOI: 10.1007/s10461-012-0190-5.
Study protocol for the recruitment of female sex workers and their non-commercial partners into couple-based HIV research.
Syvertsen J, Robertson A, Abramovitz D, Rangel M, Martinez G, Patterson T
BMC Public Health. 2012; 12:136.
PMID: 22348625
PMC: 3359230.
DOI: 10.1186/1471-2458-12-136.
Linearity and nonlinearity in HIV/STI transmission: implications for the evaluation of sexual risk reduction interventions.
Pinkerton S, Chesson H, Crosby R, Layde P
Eval Rev. 2011; 35(5):550-65.
PMID: 22201639
PMC: 4088939.
DOI: 10.1177/0193841X11432196.
"Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.
Carballo-Dieguez A, Giguere R, Dolezal C, Chen B, Kahn J, Zimet G
AIDS Behav. 2011; 16(7):1761-74.
PMID: 21863338
PMC: 3272128.
DOI: 10.1007/s10461-011-0028-6.
The cost-effectiveness of a modestly effective HIV vaccine in the United States.
Long E, Owens D
Vaccine. 2011; 29(36):6113-24.
PMID: 21510996
PMC: 3156325.
DOI: 10.1016/j.vaccine.2011.04.013.
The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States.
Long E, Brandeau M, Owens D
Ann Intern Med. 2010; 153(12):778-89.
PMID: 21173412
PMC: 3173812.
DOI: 10.7326/0003-4819-153-12-201012210-00004.
